Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 26% ± 10% | |
non-classical monocyte | 10 studies | 25% ± 10% | |
microglial cell | 10 studies | 37% ± 12% | |
myeloid cell | 10 studies | 26% ± 12% | |
macrophage | 10 studies | 33% ± 11% | |
astrocyte | 8 studies | 26% ± 9% | |
dendritic cell | 8 studies | 34% ± 11% | |
pericyte | 7 studies | 22% ± 8% | |
monocyte | 6 studies | 35% ± 10% | |
classical monocyte | 5 studies | 26% ± 7% | |
glutamatergic neuron | 5 studies | 46% ± 20% | |
neuron | 4 studies | 25% ± 7% | |
adipocyte | 4 studies | 18% ± 2% | |
lymphocyte | 4 studies | 24% ± 9% | |
GABAergic neuron | 4 studies | 44% ± 14% | |
T cell | 4 studies | 20% ± 3% | |
smooth muscle cell | 4 studies | 22% ± 2% | |
interneuron | 4 studies | 38% ± 21% | |
epithelial cell | 3 studies | 33% ± 11% | |
mononuclear phagocyte | 3 studies | 26% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 5% | |
alveolar macrophage | 3 studies | 41% ± 11% | |
endothelial cell of lymphatic vessel | 3 studies | 15% ± 0% | |
oligodendrocyte | 3 studies | 23% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3097.44 | 1445 / 1445 | 100% | 17.54 | 183 / 183 |
brain | 100% | 2444.21 | 2634 / 2642 | 100% | 23.45 | 704 / 705 |
lung | 100% | 3989.03 | 578 / 578 | 98% | 12.59 | 1130 / 1155 |
intestine | 100% | 3019.00 | 966 / 966 | 98% | 10.14 | 514 / 527 |
thymus | 100% | 2212.92 | 652 / 653 | 98% | 12.49 | 591 / 605 |
breast | 100% | 3065.75 | 459 / 459 | 97% | 13.26 | 1090 / 1118 |
skin | 100% | 2642.75 | 1807 / 1809 | 97% | 15.29 | 458 / 472 |
stomach | 99% | 2162.10 | 357 / 359 | 97% | 12.67 | 278 / 286 |
ovary | 99% | 1874.67 | 179 / 180 | 97% | 10.48 | 416 / 430 |
kidney | 100% | 1688.82 | 89 / 89 | 95% | 12.45 | 859 / 901 |
bladder | 100% | 2995.71 | 21 / 21 | 94% | 9.13 | 473 / 504 |
uterus | 100% | 3439.18 | 170 / 170 | 93% | 9.84 | 428 / 459 |
prostate | 100% | 2044.31 | 244 / 245 | 87% | 6.61 | 438 / 502 |
adrenal gland | 100% | 1820.47 | 258 / 258 | 87% | 7.60 | 199 / 230 |
pancreas | 72% | 702.43 | 237 / 328 | 95% | 10.23 | 169 / 178 |
liver | 62% | 515.62 | 139 / 226 | 39% | 2.49 | 157 / 406 |
adipose | 100% | 3620.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4892.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.70 | 29 / 29 |
spleen | 100% | 4501.52 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.84 | 1 / 1 |
peripheral blood | 99% | 7053.63 | 920 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 10.01 | 43 / 45 |
heart | 95% | 1360.22 | 814 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 6.85 | 73 / 80 |
muscle | 78% | 762.22 | 623 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033574 | Biological process | response to testosterone |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0070086 | Biological process | ubiquitin-dependent endocytosis |
GO_0010332 | Biological process | response to gamma radiation |
GO_0007165 | Biological process | signal transduction |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0014823 | Biological process | response to activity |
GO_0045471 | Biological process | response to ethanol |
GO_2000583 | Biological process | regulation of platelet-derived growth factor receptor-alpha signaling pathway |
GO_0042594 | Biological process | response to starvation |
GO_0048260 | Biological process | positive regulation of receptor-mediated endocytosis |
GO_0043303 | Biological process | mast cell degranulation |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0032487 | Biological process | regulation of Rap protein signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_0035635 | Biological process | entry of bacterium into host cell |
GO_0008584 | Biological process | male gonad development |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0036120 | Biological process | cellular response to platelet-derived growth factor stimulus |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016600 | Cellular component | flotillin complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0005929 | Cellular component | cilium |
GO_0005829 | Cellular component | cytosol |
GO_0030426 | Cellular component | growth cone |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0046875 | Molecular function | ephrin receptor binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0036312 | Molecular function | phosphatidylinositol 3-kinase regulatory subunit binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | CBL |
Protein name | E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) Alternative protein CBL Cbl proto-oncogene |
Synonyms | CBL2 RNF55 |
Description | FUNCTION: Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome . Ubiquitinates SPRY2 . Ubiquitinates EGFR . Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The 'Tyr-731' phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. May be functionally coupled with the E2 ubiquitin-protein ligase UB2D3. In association with CBLB, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA (By similarity). . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. . |
Accessions | A0A1B0GW38 A0A8V8TQA9 A0A0U1RR39 ENST00000637974.1 ENST00000634301.1 P22681 ENST00000264033.6 A0A0U1RQX8 ENST00000700472.1 A0A0U1RRJ5 L0R4V5 ENST00000634840.1 ENST00000634586.1 |